Results
1177
Companies which are more than 50% undervalued based on analyst price target.
1,177 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSTR | US$341.25 | -9.6% | 580.9% | US$83.8b | US$524.10 | PS182.3x | E59.7% | n/a | Software | ||
BIIB | US$144.41 | 1.2% | -41.5% | US$21.2b | US$228.33 | PE13x | E10.3% | n/a | Pharmaceuticals & Biotech | ||
SMMT | US$21.64 | -8.0% | 452.0% | US$17.3b | US$33.08 | PB36.4x | E38.9% | n/a | Pharmaceuticals & Biotech | ||
MRNA | US$40.72 | 5.8% | -59.7% | US$17.3b | US$63.64 | PS3.1x | E22.5% | n/a | Pharmaceuticals & Biotech | ||
FSLR | US$166.01 | -3.4% | 13.5% | US$17.2b | US$267.53 | PE14.2x | E24.3% | n/a | Semiconductors | ||
BMRN | US$63.46 | 2.3% | -28.0% | US$12.1b | US$97.16 | PE37.5x | E24.1% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$88.67 | 2.3% | 24.2% | US$11.5b | US$149.89 | PB3.2x | E27.1% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$115.45 | -0.6% | -3.0% | US$11.2b | US$184.31 | PE90.5x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
FTAI | US$97.00 | 5.4% | 79.8% | US$10.3b | US$185.51 | PS6.4x | E53.3% | 1.2% | Capital Goods | ||
VFS | US$3.82 | -7.3% | -35.8% | US$9.2b | US$6.33 | PS6x | E0.006% | n/a | Automobiles | ||
ASND | US$127.55 | 1.4% | -1.8% | US$7.7b | US$193.14 | PS22.4x | E57.9% | n/a | Pharmaceuticals & Biotech | ||
RVMD | US$40.92 | 0% | 47.5% | US$7.6b | US$73.43 | PS10191.1x | E19.8% | n/a | Pharmaceuticals & Biotech | ||
NBIS | US$29.73 | -24.8% | n/a | US$7.1b | US$50.66 | PE34.6x | S-139.4% | n/a | Software | ||
LEGN | US$36.10 | -3.6% | -34.4% | US$6.6b | US$79.83 | PS12.7x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
ANF | US$122.61 | -4.6% | 20.3% | US$6.1b | US$187.40 | PE11.5x | E4.9% | 0% | Retail | ||
CELH | US$25.36 | 0.04% | -49.2% | US$5.8b | US$38.31 | PE35x | E19.0% | n/a | Food, Beverage & Tobacco | ||
CYTK | US$48.65 | 3.9% | -37.7% | US$5.7b | US$81.61 | PS1783.6x | E43.8% | n/a | Pharmaceuticals & Biotech | ||
IONS | US$32.88 | 1.2% | -36.0% | US$5.4b | US$61.32 | PS6.5x | E40.4% | n/a | Pharmaceuticals & Biotech | ||
ASTS | US$17.72 | -10.5% | 511.0% | US$5.1b | US$35.04 | PS1420x | E57.1% | n/a | Telecom | ||
MOD | US$98.21 | -31.2% | 42.1% | US$5.0b | US$147.35 | PE31.5x | E26.5% | n/a | Automobiles | ||
IEP | US$9.86 | 3.4% | -46.0% | US$5.0b | US$15.00 | PS0.5x | E182.3% | 20.3% | Capital Goods | ||
WFRD | US$65.74 | -7.4% | -26.6% | US$4.8b | US$104.33 | PE8.9x | E4.7% | 1.5% | Energy | ||
LBTY.A | US$11.76 | 1.0% | -40.3% | US$4.3b | US$19.49 | PS0.5x | E39.7% | 85.5% | Telecom | ||
ZETA | US$18.01 | -4.6% | 86.1% | US$4.3b | US$36.92 | PS4.7x | E125.6% | n/a | Software |